Sun, Mar 1, 2015, 2:21 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

InterOil Corporation Message Board

spartanhill 1 post  |  Last Activity: Dec 5, 2014 9:09 AM Member since: Jan 22, 2003
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Data Dump..

    by blyndsquirrel1 Dec 5, 2014 8:48 AM
    spartanhill spartanhill Dec 5, 2014 9:09 AM Flag

    The just-published paper strongly supports the idea that levels of liver enzymes are good surrogate end-points for primary biliary cirrhosis (PBC), another disease that can be treated by OCA. So, Intercept is more likely to get OCA approved for primary biliary cirrhosis (which has a pretty big market, maybe $100 million a year) on the basis of liver enzyme measurements (which they already have), as opposed to waiting for the patients in the control group to actually need liver transplants. Then too, if a liver enzyme level is an acceptable endpoint for PBC, it might be OK for NASH as well.

IOC
45.80-0.09(-0.20%)Feb 27 4:02 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.